JP2019532072A5 - - Google Patents

Download PDF

Info

Publication number
JP2019532072A5
JP2019532072A5 JP2019520078A JP2019520078A JP2019532072A5 JP 2019532072 A5 JP2019532072 A5 JP 2019532072A5 JP 2019520078 A JP2019520078 A JP 2019520078A JP 2019520078 A JP2019520078 A JP 2019520078A JP 2019532072 A5 JP2019532072 A5 JP 2019532072A5
Authority
JP
Japan
Prior art keywords
phenyl
amino
sulfonyl
butyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019520078A
Other languages
English (en)
Japanese (ja)
Other versions
JP7037558B2 (ja
JP2019532072A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/056265 external-priority patent/WO2018071622A1/en
Publication of JP2019532072A publication Critical patent/JP2019532072A/ja
Publication of JP2019532072A5 publication Critical patent/JP2019532072A5/ja
Application granted granted Critical
Publication of JP7037558B2 publication Critical patent/JP7037558B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019520078A 2016-10-14 2017-10-12 3-スルホニル-5-アミノピリジン-2,4-ジオール apjアゴニスト Active JP7037558B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662408272P 2016-10-14 2016-10-14
US62/408,272 2016-10-14
PCT/US2017/056265 WO2018071622A1 (en) 2016-10-14 2017-10-12 3-sulfonyl-5-aminopyridine-2,4-diol apj agonists

Publications (3)

Publication Number Publication Date
JP2019532072A JP2019532072A (ja) 2019-11-07
JP2019532072A5 true JP2019532072A5 (enExample) 2020-11-12
JP7037558B2 JP7037558B2 (ja) 2022-03-16

Family

ID=60162318

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019520078A Active JP7037558B2 (ja) 2016-10-14 2017-10-12 3-スルホニル-5-アミノピリジン-2,4-ジオール apjアゴニスト

Country Status (7)

Country Link
US (1) US10669258B2 (enExample)
EP (1) EP3526198B1 (enExample)
JP (1) JP7037558B2 (enExample)
KR (1) KR102521956B1 (enExample)
CN (1) CN110072850B (enExample)
ES (1) ES2820223T3 (enExample)
WO (1) WO2018071622A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20191327T1 (hr) 2015-06-03 2019-11-01 Bristol Myers Squibb Co 4-hidroksi-3-(heteroaril)piridin-2-on apj agonisti za primjenju u liječenju kardiovaskularnih poremećaja
US10392347B2 (en) 2015-10-14 2019-08-27 Bristol-Myers Squibb Company 2,4-dihydroxy-nicotinamides as APJ agonists
AR106948A1 (es) 2015-12-04 2018-03-07 Bristol Myers Squibb Co Agonistas del receptor de apelina y método de uso
EP3390400B1 (en) 2015-12-16 2021-01-20 Bristol-Myers Squibb Company Heteroarylhydroxypyrimidinones as agonists of the apj receptor
WO2017218633A1 (en) 2016-06-14 2017-12-21 Bristol-Myers Squibb Company 6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1h)-one as apj agonists
KR102521955B1 (ko) 2016-06-14 2023-04-13 브리스톨-마이어스 스큅 컴퍼니 Apj 수용체 효능제로서의 4-히드록시-3-술포닐피리딘-2(1h)-온
US11046680B1 (en) 2016-11-16 2021-06-29 Amgen Inc. Heteroaryl-substituted triazoles as APJ receptor agonists
US10906890B2 (en) 2016-11-16 2021-02-02 Amgen Inc. Triazole phenyl compounds as agonists of the APJ receptor
EP3541803B1 (en) 2016-11-16 2020-12-23 Amgen Inc. Triazole pyridyl compounds as agonists of the apj receptor
EP3541802B1 (en) 2016-11-16 2025-01-01 Amgen Inc. Alkyl substituted triazole compounds as agonists of the apj receptor
EP3541792B1 (en) 2016-11-16 2020-12-23 Amgen Inc. Triazole furan compounds as agonists of the apj receptor
WO2018093577A1 (en) 2016-11-16 2018-05-24 Amgen Inc. Cycloalkyl substituted triazole compounds as agonists of the apj receptor
WO2019089335A1 (en) 2017-11-03 2019-05-09 Amgen Inc. Fused triazole agonists of the apj receptor
EP3788037A1 (en) 2018-05-01 2021-03-10 Amgen Inc. Substituted pyrimidinones as agonists of the apj receptor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2009106214A (ru) * 2006-07-26 2010-09-10 Новартис АГ (CH) Ингибиторы ундекапренилпирофосфатсинтазы
WO2015188073A1 (en) 2014-06-06 2015-12-10 Research Triangle Institute Apelin receptor (apj) agonists and uses thereof
HRP20191327T1 (hr) * 2015-06-03 2019-11-01 Bristol Myers Squibb Co 4-hidroksi-3-(heteroaril)piridin-2-on apj agonisti za primjenju u liječenju kardiovaskularnih poremećaja
US10392347B2 (en) * 2015-10-14 2019-08-27 Bristol-Myers Squibb Company 2,4-dihydroxy-nicotinamides as APJ agonists
AR106948A1 (es) 2015-12-04 2018-03-07 Bristol Myers Squibb Co Agonistas del receptor de apelina y método de uso
EP3390400B1 (en) 2015-12-16 2021-01-20 Bristol-Myers Squibb Company Heteroarylhydroxypyrimidinones as agonists of the apj receptor
MY189454A (en) 2016-03-24 2022-02-14 Bristol Myers Squibb Co 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as apj agonists
KR102521955B1 (ko) 2016-06-14 2023-04-13 브리스톨-마이어스 스큅 컴퍼니 Apj 수용체 효능제로서의 4-히드록시-3-술포닐피리딘-2(1h)-온
WO2017218633A1 (en) 2016-06-14 2017-12-21 Bristol-Myers Squibb Company 6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1h)-one as apj agonists

Similar Documents

Publication Publication Date Title
JP2019518041A5 (enExample)
JP6545199B2 (ja) 3−アミノ−1,5,6,7−テトラヒドロ−4h−インドール−4−オン類
US20090181968A1 (en) Novel 3-Bicyclocarbonylaminopyridine-2-Carboxamides or 3-Bicyclocarbonylaminopyrazine-2-Carboxamides
JP2019518036A5 (enExample)
AU2002341921B8 (en) Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
NZ542139A (en) Pyrimidin-4-one derivatives and their use as p38 kinase modulators
JP2018538304A5 (enExample)
IL259947A (en) The troirylhydroxypyrimidinones as apj receptor agonists
JP2015503529A5 (enExample)
JP2019509319A5 (enExample)
WO2017165640A1 (en) 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as apj agonists
BG107959A (bg) Заместени производни на триазол диамин като киназни инхибитори
TWI455715B (zh) 4-(4-氰基-2-硫基芳基)二氫嘧啶酮類及其用途
AU2016365340A1 (en) Apelin receptor agonists and methods of use
WO2012012478A1 (en) Aldosterone synthase inhibitors
AU2018361249A1 (en) Aminoimidazopyridazines as kinase inhibitors
TW201225957A (en) Glycine transporter inhibitor
US20040242648A1 (en) Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity
JP2011153144A (ja) 置換ピラゾール化合物
JP2008523103A (ja) Erkプロテインキナーゼのピリミジンインヒビターおよびその使用
US9096531B2 (en) Fused imidazole derivative
JP2019511466A (ja) オレキシン受容体調節因子としてのハロ置換ピペリジン
KR20250174911A (ko) 퀴놀리논 아미드 화합물 및 이의 용도
TW202328119A (zh) 唑化合物
WO2005035505A2 (en) Compounds with phosphodiesterase inhibiting and calcium channel blocking activities